Esmolol HydrochlorideThird Party Manufacturing in India

Esmolol Hydrochloride works by selectively binding to beta-1 adrenergic receptors located within myocardial tissues. It inhibits beta-1 receptors to help the body lower heart rate, arterial blood pressure, and myocardial contractility. Unlike long-acting beta-blockers, it possesses an ester linkage that undergoes rapid hydrolysis by red blood cell esterases, offering an ultra-short half-life of nine minutes. It is highly effective and well-tolerated in critical intraoperative scenarios.

Therapeutic Uses

• Supraventricular Tachycardia: Controls ventricular rate in patients experiencing atrial fibrillation or atrial flutter.
• Intraoperative Hypertension: Manages acute elevations in heart rate and blood pressure during surgical induction and intubation.

Why Manufacturers Choose Esmolol Hydrochloride

Developing Esmolol Hydrochloride third party manufacturing in India allows pharmaceutical companies to cater to cardiac ICU and anesthesia product requirements. Its ultra-short action profile makes it a mandatory emergency stock item across major hospitals. Our partner production facilities employ modern temperature and pH stabilization frameworks. Manufacturing under WHO-GMP certified partner units guarantees flawless sterility profiles and accurate dosage calibration required for high-acuity medical care.